Identification of Circulating microRNAs in Adolescent Idiopathic Scoliosis
Launched by ISTITUTO ORTOPEDICO RIZZOLI · Feb 8, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called Adolescent Idiopathic Scoliosis (AIS), which is a type of curvature of the spine that occurs in teenagers for reasons that are not fully understood. The researchers want to identify certain tiny molecules called microRNAs in the blood of patients with AIS. These microRNAs are known to be involved in bone and tissue health, and the goal is to see if they can help understand the disease better and possibly guide future diagnosis and treatment.
To participate in the study, you must be between 11 and 17 years old and have been diagnosed with idiopathic scoliosis, meaning your spine has a significant curve (more than 10 degrees) without any known cause. You should also have medical records and imaging tests available from the last two years. Healthy teens in the same age range can also join as a comparison group. Participants will not need to undergo any surgery related to the study, and they will help researchers gather important information that may lead to new ways to diagnose and understand AIS in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Cases:
- • Age between 11-17 years
- • Diagnosis of idiopathic scoliosis with a Cobb angle\> 10 °
- • Minimum follow-up of two years
- • Clinical data and radiological tests available and no surgical treatment prior to enrollment in the study
- Controls:
- • Age between 11-17 years
- • Healthy subjects not affected by orthopedic and oncological diseases
- Exclusion Criteria:
- • Severe cognitive impairment or psychiatric disorders
- • Patients with scoliosis due to secondary causes
- • Women of childbearing age must not be pregnant
About Istituto Ortopedico Rizzoli
Istituto Ortopedico Rizzoli is a renowned orthopedic research and treatment institute based in Bologna, Italy, dedicated to advancing musculoskeletal health through innovative clinical trials and cutting-edge medical practices. With a strong emphasis on research, the institute collaborates with leading experts in orthopedics, rehabilitation, and related fields to develop and evaluate new therapies and surgical techniques. Committed to improving patient outcomes, Istituto Ortopedico Rizzoli not only focuses on high-quality clinical care but also fosters a robust research environment that supports the translation of scientific findings into clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bagheria, , Italy
Patients applied
Trial Officials
Angelo Toscano, MD
Principal Investigator
Istituto Ortopedico Rizzoli
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials